Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Eloxx Pharmaceuticals, Inc. | v355122_s1a.htm |
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No. 1 to Registration Statement (No. 333-189998) on Form S-1 of Senesco Technologies, Inc. of our report dated September 11, 2013, relating to our audits of the consolidated financial statements, appearing in the Prospectus, which is part of this Registration Statement. Our report dated September 11, 2013, relating to the consolidated financial statements includes an emphasis paragraph relating to an uncertainty as to the Company's ability to continue as a going concern.
We also consent to the reference to our firm under the captions "Experts" in such Prospectus.
/s/ McGLADREY LLP
McGladrey LLP
New York, New York
September 20, 2013